Clinical trial · Interventional
Comparison of Hydro-dissection Versus Ultrasonic Aspirator in Division of Liver Parenchyma in Laparoscopic Resection
NCT03208192CI-TRIAL-00047303LLScompletedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Background: until now, there is no agreement about the safest and feasible method for liver parenchyma transection during laparoscopic liver resection. Study design: prospective, randomized, single-center The purpose of the study: comparison of short-term results of two methods of parenchyma liver transection during laparoscopic liver resection
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Liver Transection During Laparoscopic Liver Resection | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| liver transection during laparoscopic liver resection | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- ErbeJet
- description
- liver resection using a bipolar dissector (Erbe), ultracision harmonic scalpel (Ethicon) and water-jet dissector (ERBEJET 2).
- interventionNames
- Procedure: liver transection during laparoscopic liver resection
- type
- EXPERIMENTAL
- label
- Misonix
- description
- liver resection using a bipolar dissector (Erbe), ultracision harmonic scalpel (Ethicon), and ultrasonic aspirator (Misonix/SonaStar Ultrasonic Surgical Aspiration System)
- interventionNames
- Procedure: liver transection during laparoscopic liver resection
Primary outcomes (1)
- measure
- Intraoperative Blood Loss
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with benign lesions (hemangioma, focal nodular hyperplasia \[FNH\], hepatocellular adenoma, biliary cystadenoma, hydatid echinococcosis \[only with total pericystectomy\]) and malignant tumors (colorectal cancer metastases in the liver \[CRLM\], hepatocellular carcinoma \[HCC\], intrahepatic cholangiocellular carcinoma, gallbladder cancer T1b-3NxMo without invasion into bile ducts and adjacent organs), which involves laparoscopic segmental or major resection of the liver. * Gender: both, male and female * Minimum age 18 years * Maximum age: 80 years * ASA physical status I-IV * BMI up to 40 kg/m2 * No simultaneous extrahepatic intra-abdominal procedures (bile duct resection, colon resection, partial duodenum resection) * Total bilirubin up to 100mmol/l if jaundice presents in non-cirrhotic patients * If cirrhosis is present, class A and B according to CTP score Exclusion Criteria: * • Difficulty index \> 12 points (see below) * Tumor invasion of IVC or portal trunk (necessity of vascular reconstruction) * Repeated liver resection before laparoscopic resection (the single resection before is not a contraindication) * Simultaneous extra-hepatic intra-abdominal procedures (bile duct resection, colon resection etc.) * Age under 18 years * Age above 80 years * ASA physical status \>IV * BMI \> 40 kg/m2 * Total bilirubin \>100mmol/l if jaundice presents in non-cirrhotic patients * If cirrhosis is present, class C according to CTP score * Persons who are incapable of giving consent * Pregnant or breast-feeding women * Patients enlisted in other studies
References
Publications (0)
Data not yet available
No reference posted for this study.